Advertisement

Topics

Embolx, Inc. Company Profile

21:54 EDT 16th October 2018 | BioPortfolio

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper® balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. For more information, please visit www.Embolx.com.


News Articles [12 Associated News Articles listed on BioPortfolio]

EU OKs Embolx's next-gen balloon occlusion microcatheters

European regulators have granted CE mark approval for Embolx's next-generation Sniper balloon occlusion microcatheters for tr -More- 

Embolx's balloon occlusion microcatheter cleared by FDA

Embolx's Sniper balloon occlusion microcatheter has been granted 510(k) clearance by the FDA.  -More- 

FDA approves Embolx’s next generation Sniper balloon occlusion microcatheter

Medical devices maker Embolx has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its next generation Sniper balloon occlusion microcatheter for pressure-directed arterial e...

Embolx secures NIH grant to further develop pressure-directed embolization therapy

The National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded Embolx a Small Business Innovation Research (SBIR) grant valued at $2m for further development of pressure-d...

Embolx gets CE mark for Sniper balloon occlusion microcatheters

Available both in the US and Europe, the microcatheters feature a system to deliver pressure-directed arterial embolization therapy. Sniper microcatheters will enhance the therapeutic agent delivery t...

Embolx Signs Agreement With U.S. Department of Veterans Affairs for Sniper Balloon Occlusion Microcatheter

Embolx, Inc., a medical device company, announced today that the Company has received a Federal Supply Schedule contract from the U.S. Department of Veterans Affairs (VA) t...

Embolx Earns CE Mark Certification for Sniper Balloon Occlusion Microcatheters for Pressure-Directed Treatment of Tumors, Enlarged Prostate, Fibroids

Next-Generation Balloon Microcatheters Now Commercially Available in Europe Embolx, Inc., a medical device company developing microcatheters for arterial emboliz...

National Institutes of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure-Directed Embolization Therapy

Embolx, Inc., a medical device company, announced today that the Company has been awarded a Small Business Innovation Research (SBIR) grant valued at $2 million from the Na...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Embolx, Inc.

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically...

More Information about "Embolx, Inc." on BioPortfolio

We have published hundreds of Embolx, Inc. news stories on BioPortfolio along with dozens of Embolx, Inc. Clinical Trials and PubMed Articles about Embolx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embolx, Inc. Companies in our database. You can also find out about relevant Embolx, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...


Corporate Database Quicklinks



Searches Linking to this Company Record